Published in Pancreas on November 01, 2005
Nasogastric or nasojejunal feeding in predicted severe acute pancreatitis: a meta-analysis. Crit Care (2013) 1.12
Tube feeding, the microbiota, and Clostridium difficile infection. World J Gastroenterol (2010) 1.01
Nasogastric Nutrition versus Nasojejunal Nutrition in Patients with Severe Acute Pancreatitis: A Meta-Analysis of Randomized Controlled Trials. Gastroenterol Res Pract (2016) 0.88
Enteral nutrition and acute pancreatitis: a review. Gastroenterol Res Pract (2010) 0.85
A guide to enteral access procedures and enteral nutrition. Nat Rev Gastroenterol Hepatol (2009) 0.85
The management of acute and chronic pancreatitis. Gastroenterol Hepatol (N Y) (2010) 0.84
Post-pyloric feeding. World J Gastroenterol (2009) 0.83
Effect of fiber supplementation on the microbiota in critically ill patients. World J Gastrointest Pathophysiol (2011) 0.82
Nasogastric or nasointestinal feeding in severe acute pancreatitis. World J Gastroenterol (2010) 0.81
Experience in Bedside Placement, Clinical Validity, and Cost-Efficacy of a Self-Propelled Nasojejunal Feeding Tube. Nutr Clin Pract (2015) 0.77
Does the Ileal Brake Contribute to Delayed Gastric Emptying After Pancreatoduodenectomy? Dig Dis Sci (2016) 0.77
Effect of parenteral and early intrajejunal nutrition on pancreatic digestive enzyme synthesis, storage and discharge in dog models of acute pancreatitis. World J Gastroenterol (2007) 0.75
Endoscopist's approach to nutrition in the patient with pancreatitis. World J Gastrointest Endosc (2012) 0.75
Pancreatic and Intestinal Function Post Roux-en-Y Gastric Bypass Surgery for Obesity. Clin Transl Gastroenterol (2017) 0.75
Medical Management of Pain in Chronic Pancreatitis. Dig Dis Sci (2017) 0.75
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet (2002) 4.29
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab (2004) 3.65
Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med (2002) 3.55
Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis (2007) 3.01
Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction. Eur Heart J (2011) 2.32
Effect of whey on blood glucose and insulin responses to composite breakfast and lunch meals in type 2 diabetic subjects. Am J Clin Nutr (2005) 2.25
Diet, microbiota, and microbial metabolites in colon cancer risk in rural Africans and African Americans. Am J Clin Nutr (2013) 1.87
Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: results of a randomized comparative study. Am J Gastroenterol (2002) 1.85
GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine. Regul Pept (2003) 1.70
Effects of everyday life events on glucose, insulin, and glucagon dynamics in continuous subcutaneous insulin infusion-treated type 1 diabetes: collection of clinical data for glucose modeling. Diabetes Technol Ther (2011) 1.55
Somatostatin receptors. Biochim Biophys Acta (2003) 1.49
Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endocrinol Metab (2006) 1.49
Colesevelam improves insulin resistance in a diet-induced obesity (F-DIO) rat model by increasing the release of GLP-1. Am J Physiol Gastrointest Liver Physiol (2009) 1.31
GLP-1: physiological effects and potential therapeutic applications. Diabetes Obes Metab (2008) 1.22
Four weeks of treatment with liraglutide reduces insulin dose without loss of glycemic control in type 1 diabetic patients with and without residual beta-cell function. Diabetes Care (2011) 1.22
Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure. Am J Physiol Heart Circ Physiol (2010) 1.18
GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept (2005) 1.17
Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. Diabetes (2003) 1.17
Glucose-dependent insulinotropic polypeptide may enhance fatty acid re-esterification in subcutaneous abdominal adipose tissue in lean humans. Diabetes (2010) 1.16
Distinct effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 on insulin secretion and gut motility. Diabetes (2005) 1.16
Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake. Am J Clin Nutr (2007) 1.11
Early differential defects of insulin secretion and action in 19-year-old caucasian men who had low birth weight. Diabetes (2002) 1.10
Pharmacodynamics of vildagliptin in patients with type 2 diabetes during OGTT. J Clin Pharmacol (2007) 1.10
On the role of glucose-dependent insulintropic polypeptide in postprandial metabolism in humans. Am J Physiol Endocrinol Metab (2009) 1.06
Circulating leptin and thyroid dysfunction. Eur J Endocrinol (2003) 1.05
Acute effects of ghrelin administration on glucose and lipid metabolism. J Clin Endocrinol Metab (2007) 1.05
Immunoneutralization of endogenous glucagon reduces hepatic glucose output and improves long-term glycemic control in diabetic ob/ob mice. Diabetes (2006) 1.04
Environmental influences on the high mortality from colorectal cancer in African Americans. Postgrad Med J (2007) 1.03
Tube feeding, the microbiota, and Clostridium difficile infection. World J Gastroenterol (2010) 1.01
Consumption of a diet low in advanced glycation end products for 4 weeks improves insulin sensitivity in overweight women. Diabetes Care (2013) 1.00
Automated detection of hypoglycemia-induced EEG changes recorded by subcutaneous electrodes in subjects with type 1 diabetes--the brain as a biosensor. Diabetes Res Clin Pract (2010) 0.99
Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology (2003) 0.97
Glucagon-related peptide 1 (GLP-1): hormone and neurotransmitter. Regul Pept (2005) 0.97
Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice. Regul Pept (2012) 0.97
The effects of L-arabinose on intestinal sucrase activity: dose-response studies in vitro and in humans. Am J Clin Nutr (2011) 0.96
Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2. Bone (2004) 0.94
The L-α-amino acid receptor GPRC6A is expressed in the islets of Langerhans but is not involved in L-arginine-induced insulin release. Amino Acids (2012) 0.93
Effect of subcutaneous injections of PYY1-36 and PYY3-36 on appetite, ad libitum energy intake, and plasma free fatty acid concentration in obese males. Am J Physiol Endocrinol Metab (2007) 0.93
Effect of viscosity on appetite and gastro-intestinal hormones. Physiol Behav (2009) 0.92
Glucagon-like peptide-2 increases mesenteric blood flow in humans. Scand J Gastroenterol (2009) 0.91
The truncated metabolite GLP-2 (3-33) interacts with the GLP-2 receptor as a partial agonist. Regul Pept (2002) 0.91
Sensing of triacylglycerol in the gut: different mechanisms for fatty acids and 2-monoacylglycerol. J Physiol (2015) 0.91
Nutrition support during acute pancreatitis. Nutrition (2002) 0.90
Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin-angiotensin-aldosterone system in healthy men. J Clin Endocrinol Metab (2013) 0.90
Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis. Clin Gastroenterol Hepatol (2008) 0.89
Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin. Metabolism (2009) 0.89
An analysis of cosecretion and coexpression of gut hormones from male rat proximal and distal small intestine. Endocrinology (2014) 0.88
Glucagon-like peptide-1 decreases intracerebral glucose content by activating hexokinase and changing glucose clearance during hyperglycemia. J Cereb Blood Flow Metab (2012) 0.88
Association between low colonic short-chain fatty acids and high bile acids in high colon cancer risk populations. Nutr Cancer (2011) 0.87
The effect of Glucagon-Like Peptide-2 on mesenteric blood flow and cardiac parameters in end-jejunostomy short bowel patients. Regul Pept (2011) 0.86
The intestinotrophic peptide, glp-2, counteracts intestinal atrophy in mice induced by the epidermal growth factor receptor inhibitor, gefitinib. Clin Cancer Res (2007) 0.85
Normal secretion and action of the gut incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in young men with low birth weight. J Clin Endocrinol Metab (2005) 0.85
Differential postprandial lipoprotein responses in type 2 diabetic men with and without clinical evidence of a former myocardial infarction. Rev Diabet Stud (2005) 0.85
Changes of cognition and regional cerebral activity during acute hypoglycemia in normal subjects: A H2 15O positron emission tomographic study. J Neurosci Res (2009) 0.84
Dipeptidyl peptidase expression during experimental colitis in mice. Inflamm Bowel Dis (2010) 0.84
Inhibition of human pancreatic and biliary output but not intestinal motility by physiological intraileal lipid loads. Am J Physiol Gastrointest Liver Physiol (2005) 0.84
Treatment of adult short bowel syndrome patients with teduglutide. Expert Opin Pharmacother (2012) 0.84
Continuous parenteral and enteral nutrition induces metabolic dysfunction in neonatal pigs. JPEN J Parenter Enteral Nutr (2012) 0.84
KATP channel closure ameliorates the impaired insulinotropic effect of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes. J Clin Endocrinol Metab (2008) 0.83
No increased risk of hypoglycaemic episodes during 48 h of subcutaneous glucagon-like-peptide-1 administration in fasting healthy subjects. Clin Endocrinol (Oxf) (2008) 0.83
Mechanisms of gastric emptying disturbances in chronic and acute inflammation of the distal gastrointestinal tract. Am J Physiol Gastrointest Liver Physiol (2009) 0.83
Immunoneutralization of endogenous glucagon-like peptide-2 reduces adaptive intestinal growth in diabetic rats. Regul Pept (2002) 0.83
Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial. PLoS One (2013) 0.83
Defective glucose and lipid metabolism in human immunodeficiency virus-infected patients with lipodystrophy involve liver, muscle tissue and pancreatic beta-cells. Eur J Endocrinol (2005) 0.83
Involvement of endogenous glucagon-like peptide-1 in regulation of gastric motility and pancreatic endocrine secretion. Scand J Gastroenterol (2010) 0.82
Do glucagonomas always produce glucagon? Bosn J Basic Med Sci (2016) 0.82
Glucagon-like peptide-1 as a treatment for chemotherapy-induced mucositis. Gut (2012) 0.82
Differential effect of saturated and polyunsaturated fatty acids on hepatic glucose metabolism in humans. Am J Physiol Endocrinol Metab (2004) 0.82
GLP-1 receptor agonists: targeting both hyperglycaemia and disease processes in diabetes. Diabetes Res Clin Pract (2009) 0.82
Relationships among tonic and episodic aspects of motivation to eat, gut peptides, and weight before and after bariatric surgery. Surg Obes Relat Dis (2012) 0.82
Inhibitory effect of GLP-1 on gastric motility persists after vagal deafferentation in pigs. Scand J Gastroenterol (2006) 0.82
Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus. Gynecol Endocrinol (2007) 0.82
Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males. Endocr Connect (2014) 0.82
Normal physical activity obliterates the deleterious effects of a high-caloric intake. J Appl Physiol (1985) (2013) 0.81
Cognitive performance, symptoms and counter-regulation during hypoglycaemia in patients with type 1 diabetes and high or low renin-angiotensin system activity. J Renin Angiotensin Aldosterone Syst (2009) 0.81
Feeding the injured pancreas. Gastroenterology (2005) 0.81
The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters. Regul Pept (2010) 0.81
The combination of colesevelam with sitagliptin enhances glycemic control in diabetic ZDF rat model. Am J Physiol Gastrointest Liver Physiol (2012) 0.81
Transgenic rescue of adipocyte glucose-dependent insulinotropic polypeptide receptor expression restores high fat diet-induced body weight gain. J Biol Chem (2011) 0.81
GLP-1 and GLP-2 act in concert to inhibit fasted, but not fed, small bowel motility in the rat. Regul Pept (2002) 0.81
Candidacy for intestinal transplantation. Am J Gastroenterol (2006) 0.80
Updates in weight loss surgery and gastrointestinal peptides. Curr Opin Endocrinol Diabetes Obes (2015) 0.80
Postprandial insulin secretion after gastric bypass surgery: the role of glucagon-like peptide 1. Diabetes (2011) 0.80
Gliclazide directly inhibits arginine-induced glucagon release. Diabetes (2002) 0.80
Alcohol intake and its effect on some appetite-regulating hormones in man: influence of gastroprotection with sucralfate. Endocr Res (2012) 0.80
Short bowel syndrome in adults: the need for an interdisciplinary approach and coordinated care. JPEN J Parenter Enteral Nutr (2014) 0.80
Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol. BMC Cardiovasc Disord (2013) 0.80
Liraglutide for Type 2 diabetes and obesity: a 2015 update. Expert Rev Cardiovasc Ther (2015) 0.80
Nutritional immunomodulation of acute pancreatitis. Curr Gastroenterol Rep (2007) 0.79
COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES. Endocr Pract (2015) 0.78
Gastrointestinal function and metabolic control after construction of an orthotopic ileal neobladder in bladder cancer. Scand J Urol Nephrol (2007) 0.78
Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial. BMJ Open (2014) 0.78
The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects. Regul Pept (2006) 0.78
Regulation of urea synthesis during the acute-phase response in rats. Am J Physiol Gastrointest Liver Physiol (2013) 0.77
Distal gastrectomy in pancreaticoduodenectomy is associated with accelerated gastric emptying, enhanced postprandial release of GLP-1, and improved insulin sensitivity. J Gastrointest Surg (2013) 0.77
Treatment of intestinal failure: home parenteral nutrition. Nat Clin Pract Gastroenterol Hepatol (2006) 0.77
The Effect of Dietary Fish Oil in addition to Lifestyle Counselling on Lipid Oxidation and Body Composition in Slightly Overweight Teenage Boys. J Nutr Metab (2011) 0.77
Plasma glucagon-like peptide 1 and peptide YY levels are not altered in symptomatic fructose-sorbitol malabsorption. Scand J Gastroenterol (2008) 0.77
Functional and immunohistochemical evaluation of porcine neonatal islet-like cell clusters. Cell Transplant (2003) 0.76
Exogenous glucagon-like peptide-2 (GLP-2) prevents chemotherapy-induced mucositis in rat small intestine. Cancer Chemother Pharmacol (2012) 0.76